VAP prevention Evidence Based Practice Paper This is to be a 4-5 page paper (not including the title and reference page) in APA format (6th ed) answering t

VAP prevention Evidence Based Practice Paper This is to be a 4-5 page paper (not including the title and reference page) in APA format (6th ed) answering the following questions. You do not need an abstract.

1. Identify a patient problem you have had in the clinical setting.

What formal structures were in place to help address the problem?
How did you or could you use evidence to investigate the problem?
Did you have time to search for evidence? If not what were the barriers you faced?
What databases did you access for evidence and why? (be specific).

2. Find a clinical practice guideline from the National Guideline Clearinghouse archives or any other site that produces guidelines such as the American College of Cardiology CHF guidelines, that would be suitable for the patient problem you identified. Critically appraise the guideline using the AGREE II Instrument in your textbook, p 207 box 7.1.

Please follow rubric below. First formulate PICOT question

5-6 peer review articles Rubric: Foundations of Evidence Based Practice
Identifies a patient
problem.
Formal structures
Use of evidence
Barriers
Databases
Clinical Practice
Guideline
Guideline
Appraisal
APA Format
Clearly identifies a patient problem in the clinical setting.
Scope of problem, implications of problem and goals in
resolving problem.
0-2 points
Clearly identifies formal structures in place to help address
the problem. Includes department(s), key players and goals
0- 2 points
Clearly identifies the use of evidence in addressing the
problem.
0- 2 points
Identifies barriers in searching for evidence.
0- 2 points
Clearly identifies databases that were accessed in
researching the problem.
0- 2 points
Identifies an appropriate Clinical Practice Guideline related
to the patient problem and what the specifics of the
guideline are.
0-3 points
Appraises the clinical practice guideline using the AGREE
II instrument from the textbook.
0-10 points
Paper is consistently documented in APA format 6th ed.
0-2 points
Timeliness of
submission.
Total Possible
There will be a 1 point deduction/day up to 3 days max. for
a late submission.
25 points
DOMAIN 1. SCOPE AND PURPOSE
Agree II Instrument
1. The overall objective(s) of the guideline is (are) specifically described.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
2. The health question(s) covered by the guideline is (are) specifically described.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
3. The population (patients, public, etc.) to whom the guideline is meant to apply is
specifically described.
1
Strongly Disagree
Comments
1
2
3
4
5
6
7
Strongly Agree
DOMAIN 2. STAKEHOLDER INVOLVEMENT
2
4. The guideline development group includes individuals from all relevant professional
groups.and preferences have been sought.
views
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
5. The views and preferences of the target population (patients, public, etc.) have been
sought.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
6
7
Strongly Agree
Comments
6. The target users of the guideline are clearly defined.
1
Strongly Disagree
Comments
3
2
3
4
5
DOMAIN 3. RIGOUR OF DEVELOPMENT
4
7. Systematic methods were used to search for evidence.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
8. The criteria for selecting the evidence are clearly described.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
9. The strengths and limitations of the body of evidence are clearly described.
1
Strongly Disagree
Comments
5
2
3
4
5
6
7
Strongly Agree
DOMAIN 3. RIGOUR OF DEVELOPMENT continued
6
10. The methods for formulating the recommendations are clearly described.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
11. The health benefits, side effects, and risks have been considered in formulating the
recommendations.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
DOMAIN 3. RIGOUR OF DEVELOPMENT continued
12. There is an explicit link between the recommendations and the supporting
evidence.
1
Strongly Disagree
Comments
7
2
3
4
5
6
7
Strongly Agree
DOMAIN 3. RIGOUR OF DEVELOPMENT continued
8
13. The guideline has been externally reviewed by experts prior to its publication.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
6
7
Strongly Agree
Comments
14. A procedure for updating the guideline is provided.
1
Strongly Disagree
Comments
9
2
3
4
5
DOMAIN 4. CLARITY OF PRESENTATION
10
15. The recommendations are specific and unambiguous.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
16. The different options for management of the condition or health issue are clearly
presented.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
DOMAIN 5. APPLICABILITY
17. Key recommendations are easily identifiable.
1
Strongly Disagree
Comments
11
2
3
4
5
6
7
Strongly Agree
DOMAIN 5. APPLICABILITY
12
18. The guideline describes facilitators and barriers to its application.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
19. The guideline provides advice and/or tools on how the recommendations can be
put into practice.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
20. The potential resource implications of applying the recommendations have been
considered.
1
Strongly Disagree
Comments
13
2
3
4
5
6
7
Strongly Agree
DOMAIN 5. APPLICABILITY continued
14
21. The guideline presents monitoring and/or auditing criteria.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
DOMAIN 6. EDITORIAL INDEPENDENCE
15
DOMAIN 6. EDITORIAL INDEPENDENCE
16
22. The views of the funding body have not influenced the content of the guideline.
1
Strongly Disagree
2
3
4
5
6
7
Strongly Agree
Comments
23. Competing interests of guideline development group members have been recorded
and addressed.
1
Strongly Disagree
Comments
17
2
3
4
5
6
7
Strongly Agree
OVERALL GUIDELINE ASSESSMENT
For each question, please choose the response which best characterizes the guideline
assessed:
1. Rate the overall quality of this guideline.
1
Lowest possible
quality
2
3
4
2. I would recommend this guideline for use.
Yes
Yes, with modifications
No
NOTES
18
5
6
7
Highest possible
quality
19

Purchase answer to see full
attachment